ARTICLE | Company News
Serametrix Corp. sales and marketing update
April 26, 2010 7:00 AM UTC
Serametrix launched its Seromic Profiling Assay to measure serum antibodies to tumor antigen NY-ESO-1 for worldwide research use. The company received rights from the Ludwig Institute for Cancer Resea...